In addition, KDM4B is not only required for enhancing androgen receptor (AR) transcriptional activity through histone modification, but it also enhances AR protein stability via inhibition of AR ubiquitination [105], demonstrating the functional connection between AR and KDM4B in prostate cancer. Here, KDM4B is linked to prostate cancer.